![]() |
Trials |
Immunochemotherapy in Primary Central Nervous System Lymphoma with Rituximab, HD-MTX, HD-Ara C, cyclophosphamide, ifosfamide, vincristine,vindesine, temozolomi-de and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomiCancer type: Lymphoma Phase: II Principal Investigator: Leppä Sirpa Country: FI Keywords: Finland Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01458730?term=NCT01458730&rank=1 |